Related references
Note: Only part of the references are listed.De novo hepatocellular carcinoma of liver allograft: A neglected issue
Franco Trevisani et al.
CANCER LETTERS (2015)
Temporal Trends of Nonalcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma in the Veteran Affairs Population
Sahil Mittal et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
Potential Role of the Donor in Hepatocellular Carcinoma Recurrence After Liver Transplantation
Parsia A. Vagefi et al.
LIVER TRANSPLANTATION (2015)
Benefit of Treating Hepatocellular Carcinoma Recurrence after Liver Transplantation and Analysis of Prognostic Factors for Survival in a Large Euro-American Series
G. Sapisochin et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Sorafenib for the treatment of recurrent hepatocellular carcinoma after liver transplantation: does mTOR inhibitors association augment toxicity?
Giovanni Perricone et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2014)
Sorafenib efficacy for treatment of HCC recurrence after liver transplantation is an open issue
Andrea Mancuso et al.
JOURNAL OF HEPATOLOGY (2014)
Laparoscopic microwave thermal ablation for late recurrence of local hepatocellular carcinoma after liver transplant: case report
Enrico Gringeri et al.
PROGRESS IN TRANSPLANTATION (2014)
Efficacy and Safety of Combination Therapy With Everolimus and Sorafenib for Recurrence of Hepatocellular Carcinoma After Liver Transplantation
P. De Simone et al.
TRANSPLANTATION PROCEEDINGS (2014)
Clinical analysis of recurrent hepatocellular carcinoma after living donor liver transplantation
Young Chul Yoon et al.
CLINICAL TRANSPLANTATION (2013)
Safety and efficacy of sorafenib for the treatment of recurrent hepatocellular carcinoma after liver transplantation
Abhijeet Waghray et al.
CLINICAL TRANSPLANTATION (2013)
Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012
J. Ferlay et al.
EUROPEAN JOURNAL OF CANCER (2013)
Factors predicting survival after post-transplant hepatocellular carcinoma recurrence
Christian Toso et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2013)
Comparative efficacy of sorafenib versus best supportive care in recurrent hepatocellular carcinoma after liver transplantation: A case-control study
Carlo Sposito et al.
JOURNAL OF HEPATOLOGY (2013)
Integrating sorafenib into an algorithm for the management of post-transplant hepatocellular carcinoma recurrence
Christian Toso et al.
JOURNAL OF HEPATOLOGY (2013)
Sorafenib treatment is save and may affect survival of recurrent hepatocellular carcinoma after liver transplantation
Jan Pfeiffenberger et al.
LANGENBECKS ARCHIVES OF SURGERY (2013)
Recurrent hepatocellular carcinoma after liver transplantation - an emerging clinical challenge
Martin-Walter Welker et al.
TRANSPLANT INTERNATIONAL (2013)
Liver Resection in Transplanted Patients: A Single-Center Western Experience
D. Sonnmacale et al.
TRANSPLANTATION PROCEEDINGS (2013)
Sorafenib for recurrence of hepatocellular carcinoma after liver transplantation
Arndt Weinmann et al.
DIGESTIVE AND LIVER DISEASE (2012)
Outcome and survival analysis of pulmonary metastasectomy for hepatocellular carcinoma
Kentaro Kitano et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2012)
Liver Transplantation for Hepatocellular Carcinoma: A Model Including α-Fetoprotein Improves the Performance of Milan Criteria
Christophe Duvoux et al.
GASTROENTEROLOGY (2012)
Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report
Pierre-Alain Clavien et al.
LANCET ONCOLOGY (2012)
Efficacy and safety of sorafenib in combination with mammalian target of rapamycin inhibitors for recurrent hepatocellular carcinoma after liver transplantation
Carlos Gomez-Martin et al.
LIVER TRANSPLANTATION (2012)
High toxicity of sorafenib for recurrent hepatocellular carcinoma after liver transplantation
Katharina Staufer et al.
TRANSPLANT INTERNATIONAL (2012)
Sorafenib Treatment for Recurrent Hepatocellular Carcinoma After Liver Transplantation
G. C. Sotiropoulos et al.
TRANSPLANTATION PROCEEDINGS (2012)
Sorafenib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplantation?
A. Vitale et al.
TRANSPLANTATION PROCEEDINGS (2012)
Resection of Pulmonary Metastases from Hepatocellular Carcinoma following Liver Transplantation
Shin Hwang et al.
WORLD JOURNAL OF SURGERY (2012)
Hepatic Artery Chemoembolization for Hepatocellular Carcinoma Recurrence Confined to the Transplanted Liver
Brian I. Carr
CASE REPORTS IN ONCOLOGY (2012)
Liver Transplantation for Hepatocellular Carcinoma: Five Steps to Prevent Recurrence
C. Toso et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2011)
Treatment of recurrent hepatocellular carcinoma after liver transplantation
Hye Ryun Kim et al.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2011)
mTOR inhibitors and sorafenib for recurrent heptocellular carcinoma after orthotopic liver transplantation
Oliver Waidmann et al.
JOURNAL OF HEPATOLOGY (2011)
Inhibition of mammalian target of rapamycin: Two goals with one shot?
Christopher Soll et al.
JOURNAL OF HEPATOLOGY (2011)
Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplantation
Eric Davis et al.
LIVER TRANSPLANTATION (2011)
Using Sorafenib for Recurrent Hepatocellular Carcinoma After Liver Transplantation-Interactions Between Calcineurin Inhibitor: Two Case Reports
T. Takahara et al.
TRANSPLANTATION PROCEEDINGS (2011)
Late Recurrence of Hepatocellular Carcinoma after Liver Transplantation
Kenneth S. H. Chok et al.
WORLD JOURNAL OF SURGERY (2011)
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Julian P. T. Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Sorafenib extends the survival time of patients with multiple recurrences of hepatocellular carcinoma after liver transplantation
Wei-feng Tan et al.
ACTA PHARMACOLOGICA SINICA (2010)
Improved Results of a Surgical Resection for the Recurrence of Hepatocellular Carcinoma After Living Donor Liver Transplantation
Akinobu Taketomi et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Long-term survival after recurrent hepatocellular carcinoma in liver transplant patients: Clinical patterns and outcome variables
A. Kornberg et al.
EJSO (2010)
Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
Andreas Stang
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2010)
Sirolimus-Based Immunosuppression Is Associated with Increased Survival After Liver Transplantation for Hepatocellular Carcinoma
Christian Toso et al.
HEPATOLOGY (2010)
A Case of Recurred Hepatocellular Carcinoma Refractory to Doxorubicin After Liver Transplantation Showing Response to Herbal Medicine Product, Rhus verniciflua Stokes Extract
Hye Ryun Kim et al.
INTEGRATIVE CANCER THERAPIES (2010)
Sorafenib for Recurrent Hepatocellular Carcinoma After Liver Transplantation
Dok Hyun Yoon et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2010)
Hepatocellular Carcinoma: Consensus Recommendations of the National Cancer Institute Clinical Trials Planning Meeting
Melanie B. Thomas et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Personalized molecular targeted therapy in advanced, recurrent hepatocellular carcinoma after liver transplantation: A proof of principle
Sherrie Bhoori et al.
JOURNAL OF HEPATOLOGY (2010)
Chemoembolization with Lobaplatin Mixed with Iodized Oil for Unresectable Recurrent Hepatocellular Carcinoma after Orthotopic Liver Transplantation
Bin Zhou et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2010)
Prognostic Factors Affecting Survival After Recurrence in Adult Living Donor Liver Transplantation for Hepatocellular Carcinoma
Woo Young Shin et al.
LIVER TRANSPLANTATION (2010)
Role of surgical resection for pulmonary metastasis of hepatocellular carcinoma
Kook Nam Han et al.
LUNG CANCER (2010)
Safety and Feasibility of Using Sorafenib in Recurrent Hepatocellular Carcinoma after Orthotopic Liver Transplantation
Richard Kim et al.
ONCOLOGY (2010)
Effect of Different Immunosuppressive Schedules on Recurrence-Free Survival After Liver Transplantation for Hepatocellular Carcinoma
Marco Vivarelli et al.
TRANSPLANTATION (2010)
Sorafenib-Induced Severe Acute Hepatitis in a Stable Liver Transplant Recipient
Uta Herden et al.
TRANSPLANTATION (2010)
Management of Hepatocellular Carcinoma Recurrence After Liver Transplantation
A. Valdivieso et al.
TRANSPLANTATION PROCEEDINGS (2010)
Apparent Remission of a Solitary Metastatic Pulmonary Lesion in a Liver Transplant Recipient Treated with Sorafenib
M. Yeganeh et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Natural history and therapeutic management of recurrent hepatocellular carcinoma after liver transplantation
A. Hollebecque et al.
GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE (2009)
Reassessing Selection Criteria Prior to Liver Transplantation for Hepatocellular Carcinoma Utilizing the Scientific Registry of Transplant Recipients Database
Christian Toso et al.
HEPATOLOGY (2009)
Palliative chemotherapy for patients with recurrent hepatocellular carcinoma after liver transplantation
Jeong-Ok Lee et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2009)
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis
Vincenzo Mazzaferro et al.
LANCET ONCOLOGY (2009)
Impact of Sirolimus on the Recurrence of Hepatocellular Carcinoma After Liver Transplantation
Srinath Chinnakotla et al.
LIVER TRANSPLANTATION (2009)
Efficacy, Tolerance, and Safety of Mammalian Target of Rapamycin Inhibitors as Rescue Immunosuppressants in Liver Transplantation
J. M. Alamo et al.
TRANSPLANTATION PROCEEDINGS (2009)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
Pulmonary resection of metastatic hepatocellular carcinoma after liver transplantation
Michael J. Bates et al.
ANNALS OF THORACIC SURGERY (2008)
Recurrence of hepatocellular carcinoma following liver transplantation - A review of preoperative and postoperative prognostic indicators
Michael A. Zimmerman et al.
ARCHIVES OF SURGERY (2008)
GRADE:: an emerging consensus on rating quality of evidence and strength of recommendations
Gordon H. Guyatt et al.
BRITISH MEDICAL JOURNAL (2008)
Radiofrequency ablation of recurrent hepatocellular carcinoma in a patient after liver transplantation: Two-year follow-up
Chanda K. Ho et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2007)
Recurrence of hepatocellular carcinoma after liver transplantation
A. Escartin et al.
TRANSPLANTATION PROCEEDINGS (2007)
Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis
Hashem B. El-Serag et al.
GASTROENTEROLOGY (2007)
Selection of patients with hepatocellular carcinoma for liver transplantation
R Sutcliffe et al.
BRITISH JOURNAL OF SURGERY (2006)
Successful use of sirolimus in a patient with bulky ovarian metastasis of hepatocellular carcinoma after liver transplantation
DL Stippel et al.
TRANSPLANTATION PROCEEDINGS (2005)
Analysis of risk factors for tumor recurrence after liver transplantation for hepatocellular carcinoma: Key role of immunosuppression
M Vivarelli et al.
LIVER TRANSPLANTATION (2005)
Recurrence of hepatocellular carcinoma after liver transplant: Patterns and prognosis
S Roayaie et al.
LIVER TRANSPLANTATION (2004)
Hepatic resection after liver transplantation as a graft-saving procedure:: Indication criteria, timing and outcome
G Catalano et al.
TRANSPLANTATION PROCEEDINGS (2004)
Hepatocellular carcinoma and hepatitis C in the United States
HB El-Serag
HEPATOLOGY (2002)
Liver transplantation for hepatocellular carcinoma: Comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria
FY Yao et al.
LIVER TRANSPLANTATION (2002)
Share Paper
